[HTML][HTML] Treatment for patients with malignant pheochromocytomas and paragangliomas: a perspective from the hallmarks of cancer

C Jimenez - Frontiers in endocrinology, 2018 - frontiersin.org
Malignant pheochromocytomas and paragangliomas affect a very small percentage of the
general population. A substantial number of these patients have a hereditary predisposition …

Treatment for Patients With Malignant Pheochromocytomas and Paragangliomas: A Perspective From the Hallmarks of Cancer

C Jimenez - Frontiers in endocrinology, 2018 - pubmed.ncbi.nlm.nih.gov
Malignant pheochromocytomas and paragangliomas affect a very small percentage of the
general population. A substantial number of these patients have a hereditary predisposition …

Treatment for Patients With Malignant Pheochromocytomas and Paragangliomas: A Perspective From the Hallmarks of Cancer.

C Jimenez - Frontiers in Endocrinology, 2018 - europepmc.org
Malignant pheochromocytomas and paragangliomas affect a very small percentage of the
general population. A substantial number of these patients have a hereditary predisposition …

Treatment for Patients with Malignant Pheochromocytomas and Paragangliomas: A Perspective From the Hallmarks of Cancer

C Jimenez - What's New in Endocrinology?, 2020 - books.google.com
Malignant pheochromocytomas and paragangliomas affect a very small percentage of the
general population. A substantial number of these patients have a hereditary predisposition …

[HTML][HTML] Treatment for Patients With Malignant Pheochromocytomas and Paragangliomas: A Perspective From the Hallmarks of Cancer

C Jimenez - Frontiers in Endocrinology, 2018 - ncbi.nlm.nih.gov
Malignant pheochromocytomas and paragangliomas affect a very small percentage of the
general population. A substantial number of these patients have a hereditary predisposition …

Treatment for patients with malignant pheochromocytomas and paragangliomas: A perspective from the hallmarks of cancer

C Jimenez - Frontiers in Endocrinology, 2018 - mdanderson.elsevierpure.com
Malignant pheochromocytomas and paragangliomas affect a very small percentage of the
general population. A substantial number of these patients have a hereditary predisposition …